J Gastrointest Cancer. 2017 Nov 22. doi: 10.1007/s12029-017-0027-6. [Epub ahead of print]
Treatment Patterns and Outcomes in Patients with KRAS Wild-Type Metastatic Colorectal Cancer Treated in First Line with Bevacizumab- or Cetuximab-Containing Regimens.
Community oncology; Comparative effectiveness; Overall survival; Progression-free survival; Tumor location